Table 5.
Effects of gene-gene interactions on folate deficiency.
Genotype 1 | Genotype 2 | NL/NH 1 | OR (95%Cl) | p 2 | Trend test | p 2 | |
---|---|---|---|---|---|---|---|
MTHFR C677T | MTHFR A1298C | ||||||
CC + CT | AC + CC | 33/109 | Reference | 0.16 (0.02) | <0.001 | ||
CC + CT | AA | 50/160 | 1.09 (0.65–1.82) | 0.757 | |||
TT | AC + CC | 0/0 | - | - | |||
TT | AA | 48/68 | 2.45 (1.41–4.28) | 0.002 | |||
MTHFR C677T | MTR A2756G | ||||||
CC + CT | AA | 65/225 | Reference | 0.19 (0.02) | <0.001 | ||
CC + CT | AG + GG | 18/44 | 1.69 (0.88–3.23) | 0.116 | |||
TT | AA | 35/57 | 2.22 (1.32–3.74) | 0.003 | |||
TT | AG + GG | 13/11 | 4.13 (1.68–10.13) | 0.002 | |||
MTHFR C677T | MTRR A66G | ||||||
CC + CT | AA | 29/91 | Reference | 0.15 (0.02) | 0.001 | ||
CC + CT | AG + GG | 54/178 | 1.02 (0.60–1.73) | 0.954 | |||
TT | AA | 12/21 | 2.03 (0.84–4.87) | 0.114 | |||
TT | AG + GG | 36/47 | 2.50 (1.33–4.67) | 0.004 | |||
MTHFR A1298C | MTR A2756G | ||||||
AC + CC | AA | 26/92 | Reference | 0.11 (0.02) | 0.019 | ||
AC + CC | AG + GG | 7/17 | 2.07 (0.72–5.92) | 0.177 | |||
AA | AA | 74/190 | 1.50 (0.89–2.54) | 0.131 | |||
AA | AG + GG | 24/38 | 2.54 (1.26–5.15) | 0.010 | |||
MTHFR A1298C | MTRR A66G | ||||||
AC + CC | AA | 13/38 | Reference | 0.08 (0.02) | 0.088 | ||
AC + CC | AG + GG | 20/71 | 0.87 (0.38–1.99) | 0.743 | |||
AA | AA | 28/74 | 1.18 (0.54–2.60) | 0.680 | |||
AA | AG + GG | 70/154 | 1.46 (0.72–2.98) | 0.297 | |||
MTR A2756G | MTRR A66G | ||||||
AA | AA | 30/93 | Reference | 0.10 (0.02) | 0.032 | ||
AA | AG + GG | 70/189 | 1.16 (0.69–1.94) | 0.570 | |||
AG + GG | AA | 11/19 | 1.73 (0.70–4.29) | 0.240 | |||
AG + GG | AG + GG | 20/36 | 2.09 (1.01–4.29) | 0.046 |
1 NL: number of low folate patients (<10 nmol/L); NH: number of high folate patients (≥10 nmol/L); 2 Adjusted for sex, age, clinical center, height, and weight.